Shanghai Haohai Biological Technology (688366) Revenue Breakdown - Main Composition

42.02
-0.33-0.78%

Market Closed Mar 12 15:00 CST

9.66BMarket Cap25.15P/E (TTM)

Shanghai Haohai Biological Technology (688366) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

医疗美容与创面护理产品575.45M44.12%

Ophthalmic products367.54M28.18%

Orthopedic products226.81M17.39%

防粘连及止血产品110.39M8.46%

Other products24.21M1.86%

By Industry

Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical manufacturing industry2.69B99.83%

Other business4.72M0.17%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

China Mainland1.09B83.34%

Europe83.04M6.37%

Other countries / areas75.19M5.76%

United States of America59.12M4.53%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.